lncRNA requirements for mouse acute myeloid leukemia and normal differentiation

  1. M Joaquina Delás
  2. Leah R Sabin
  3. Egor Dolzhenko
  4. Simon RV Knott
  5. Ester Munera Maravilla
  6. Benjamin T Jackson
  7. Sophia A Wild
  8. Tatjana Kovacevic
  9. Eva Maria Stork
  10. Meng Zhou
  11. Nicolas Erard
  12. Emily Lee
  13. David R Kelley
  14. Mareike Roth
  15. Inês AM Barbosa
  16. Johannes Zuber
  17. John L Rinn
  18. Andrew D Smith  Is a corresponding author
  19. Gregory J Hannon  Is a corresponding author
  1. Cold Spring Harbor Laboratory, United States
  2. University of Southern California, United States
  3. University of Cambridge, United Kingdom
  4. Watson School of Biological Sciences, United States
  5. Harvard University, United States
  6. Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Austria
  7. Cold Spring Harbor Laboratory, United Kingdom

Abstract

A substantial fraction of the genome is transcribed in a cell type-specific manner, producing long non-coding RNAs (lncRNAs), rather than protein-coding transcripts. Here we systematically characterize transcriptional dynamics during hematopoiesis and in hematological malignancies. Our analysis of annotated and de novo assembled lncRNAs showed many are regulated during differentiation and mis-regulated in disease. We assessed lncRNA function via an in vivo RNAi screen in a model of acute myeloid leukemia. This identified several lncRNAs essential for leukemia maintenance, and found that a number act by promoting leukemia stem cell signatures. Leukemia blasts show a myeloid differentiation phenotype when these lncRNAs were depleted, and our data indicates that this effect is mediated via effects on the c-MYC oncogene. Bone marrow reconstitutions showed that a lncRNA expressed across all progenitors was required for the myeloid lineage, whereas the other leukemia-induced lncRNAs were dispensable in the normal setting.

Data availability

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. M Joaquina Delás

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9727-9068
  2. Leah R Sabin

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Egor Dolzhenko

    Molecular and Computational Biology, University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Simon RV Knott

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ester Munera Maravilla

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Benjamin T Jackson

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Sophia A Wild

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Tatjana Kovacevic

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Eva Maria Stork

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Meng Zhou

    Molecular and Computational Biology, University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Nicolas Erard

    Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Emily Lee

    Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. David R Kelley

    Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Mareike Roth

    Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  15. Inês AM Barbosa

    Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  16. Johannes Zuber

    Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8810-6835
  17. John L Rinn

    Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Andrew D Smith

    Molecular and Computational Biology, University of Southern California, Los Angeles, United States
    For correspondence
    andrewds@usc.edu
    Competing interests
    The authors declare that no competing interests exist.
  19. Gregory J Hannon

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United Kingdom
    For correspondence
    greg.hannon@cruk.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4021-3898

Funding

Cancer Research UK

  • Gregory J Hannon

Boehringer Ingelheim Fonds (PhD Fellowship)

  • M Joaquina Delás

Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona " (Graduate Studies Fellowship)

  • M Joaquina Delás

National Institutes of Health (R01 HG007650)

  • Andrew D Smith

Damon Runyon Cancer Research Foundation (DRG-2016-12)

  • Leah R Sabin

Howard Hughes Medical Institute (Investigator)

  • Gregory J Hannon

Wellcome Trust (Investigator)

  • Gregory J Hannon

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: For animal experiments conducted at Cold Spring Harbor Laboratory, all the animals were handled according to the approved institutional animal care and use committee (IACUC) protocol (#14-11-18). For animal experiments conducted at CRUK Cambridge Institute, all the animals were handled according to project and personal licenses issued under the United Kingdom Animals (Scientific Procedures) Act, 1986 (PPL 70/8391).

Copyright

© 2017, Delás et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,278
    views
  • 698
    downloads
  • 58
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. M Joaquina Delás
  2. Leah R Sabin
  3. Egor Dolzhenko
  4. Simon RV Knott
  5. Ester Munera Maravilla
  6. Benjamin T Jackson
  7. Sophia A Wild
  8. Tatjana Kovacevic
  9. Eva Maria Stork
  10. Meng Zhou
  11. Nicolas Erard
  12. Emily Lee
  13. David R Kelley
  14. Mareike Roth
  15. Inês AM Barbosa
  16. Johannes Zuber
  17. John L Rinn
  18. Andrew D Smith
  19. Gregory J Hannon
(2017)
lncRNA requirements for mouse acute myeloid leukemia and normal differentiation
eLife 6:e25607.
https://doi.org/10.7554/eLife.25607

Share this article

https://doi.org/10.7554/eLife.25607

Further reading

    1. Developmental Biology
    Emily Delgouffe, Samuel Madureira Silva ... Ellen Goossens
    Research Article

    Although the impact of gender-affirming hormone therapy (GAHT) on spermatogenesis in trans women has already been studied, data on its precise effects on the testicular environment is poor. Therefore, this study aimed to characterize, through histological and transcriptomic analysis, the spermatogonial stem cell niche of 106 trans women who underwent standardized GAHT, comprising estrogens and cyproterone acetate. A partial dedifferentiation of Sertoli cells was observed, marked by the co-expression of androgen receptor and anti-Müllerian hormone which mirrors the situation in peripubertal boys. The Leydig cells also exhibited a distribution analogous to peripubertal tissue, accompanied by a reduced insulin-like factor 3 expression. Although most peritubular myoid cells expressed alpha-smooth muscle actin 2, the expression pattern was disturbed. Besides this, fibrosis was particularly evident in the tubular wall and the lumen was collapsing in most participants. A spermatogenic arrest was also observed in all participants. The transcriptomic profile of transgender tissue confirmed a loss of mature characteristics - a partial rejuvenation - of the spermatogonial stem cell niche and, in addition, detected inflammation processes occurring in the samples. The present study shows that GAHT changes the spermatogonial stem cell niche by partially rejuvenating the somatic cells and inducing fibrotic processes. These findings are important to further understand how estrogens and testosterone suppression affect the testis environment, and in the case of orchidectomized testes as medical waste material, their potential use in research.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Kara A Nelson, Kari F Lenhart ... Stephen DiNardo
    Research Article

    Niches are often found in specific positions in tissues relative to the stem cells they support. Consistency of niche position suggests that placement is important for niche function. However, the complexity of most niches has precluded a thorough understanding of how their proper placement is established. To address this, we investigated the formation of a genetically tractable niche, the Drosophila Posterior Signaling Center (PSC), the assembly of which had not been previously explored. This niche controls hematopoietic progenitors of the lymph gland (LG). PSC cells were previously shown to be specified laterally in the embryo, but ultimately reside dorsally, at the LG posterior. Here, using live-imaging, we show that PSC cells migrate as a tight collective and associate with multiple tissues during their trajectory to the LG posterior. We find that Slit emanating from two extrinsic sources, visceral mesoderm and cardioblasts, is required for the PSC to remain a collective, and for its attachment to cardioblasts during migration. Without proper Slit-Robo signaling, PSC cells disperse, form aberrant contacts, and ultimately fail to reach their stereotypical position near progenitors. Our work characterizes a novel example of niche formation and identifies an extrinsic signaling relay that controls precise niche positioning.